metaraminol has been researched along with Adrenal Cancer in 2 studies
Metaraminol: A sympathomimetic agent that acts predominantly at alpha-1 adrenergic receptors. It has been used primarily as a vasoconstrictor in the treatment of HYPOTENSION.
metaraminol : A member of the class of phenylethanolamines that is 2-amino-1-phenylethanol substituted by a methyl group at position 2 and a phenolic hydroxy group at position 1. A sympathomimetic agent , it is used in the treatment of hypotension.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horwitz, D | 1 |
| Alexander, RW | 1 |
| Lovenberg, W | 1 |
| Keiser, HR | 1 |
| Maebashi, M | 1 |
| Miura, Y | 1 |
| Yoshinaga, K | 1 |
| Sato, K | 1 |
2 other studies available for metaraminol and Adrenal Cancer
| Article | Year |
|---|---|
Human serum dopamine- -hydroxylase. Relationship to hypertension and sympathetic activity.
Topics: Adrenal Gland Neoplasms; Adult; Amphetamine; Blood Flow Velocity; Blood Pressure; Dopamine beta-Hydr | 1973 |
Plasma renin activity in pheochromocytoma.
Topics: Adolescent; Adrenal Gland Neoplasms; Adult; Animals; Blood Pressure; Dogs; Epinephrine; Female; Hema | 1968 |